Velarion Records
Free. Unsubscribe any time.

Dyne Therapeutics, Inc. (DYN)

Dyne Therapeutics, Inc. filed 52 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 8 reporting owners, covering 138 transactions and 7,639,392 shares. 44 carry the SEC's AFF10B5ONE flag; 8 name a plan only in a footnote. 9 results prints are on file in the same window.

What stands out

Trades in Dyne Therapeutics, Inc. 138

Adoption dates in Dyne Therapeutics, Inc. 2

Results prints in Dyne Therapeutics, Inc. 9

Trades before a print in Dyne Therapeutics, Inc. 6

Interval to Dyne Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Dyne Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on March 19, 2026”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.